Finance

Lists
Why is SMNR down 22.33%?
Dive Deeper
SMNR:OTCMKTS
Semnur Pharmaceuticals Inc
$0.40
-22.33%
(-0.11) 1D
Oct 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMNR...
Open
$0.51
High
$0.52
Low
$0.39
Mkt. cap
92.79M
Avg. vol.
4.24K
Volume
772.00
52-wk high
$23.00
52-wk low
$0.13
Beta
-109.28
Shares outstanding
230.21M
No. of employees
5
Open
$0.51
High
$0.52
Low
$0.39
Mkt. cap
92.79M
Avg. vol.
4.24K
Volume
772.00
52-wk high
$23.00
52-wk low
$0.13
Beta
-109.28
Shares outstanding
230.21M
No. of employees
5
News stories
From web sources and news partners
About Semnur Pharmaceuticals Inc
CEO-
Employees5
Founded2013
HeadquartersPalo Alto, California, United States
SectorPharmaceutical industry
Websitesemnurpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.14M
714.00K
1.27M
1.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151.45M
5.44M
3.31M
2.98M
Operating expense
152.59M
6.16M
4.58M
4.22M
Total operating expenses
152.59M
6.16M
4.58M
4.22M
Operating income
-152.59M
-6.16M
-4.58M
-4.22M
Other non operating income
-
-
-
-
EBT including unusual items
-152.59M
-6.16M
-4.58M
-4.35M
EBT excluding unusual items
-152.59M
-6.16M
-4.58M
-4.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-152.59M
-6.16M
-4.58M
-4.35M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-123.00K
Net interest expenses
-
-
-
-123.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps